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Abstract: Although BRACO19 is a potent G-quadruplex binder, its potential for clinical usage is
hindered by its low selectivity towards DNA G-quadruplex over duplex. High-resolution structures
of BRACO19 in complex with neither single-stranded telomeric DNA G-quadruplexes nor B-DNA
duplex are available. In this study, the binding pathway of BRACO19 was probed by 27.5 µs
molecular dynamics binding simulations with a free ligand (BRACO19) to a DNA duplex and three
different topological folds of the human telomeric DNA G-quadruplex (parallel, anti-parallel and
hybrid). The most stable binding modes were identified as end stacking and groove binding for
the DNA G-quadruplexes and duplex, respectively. Among the three G-quadruplex topologies,
the MM-GBSA binding energy analysis suggested that BRACO190 s binding to the parallel scaffold
was most energetically favorable. The two lines of conflicting evidence plus our binding energy
data suggest conformation-selection mechanism: the relative population shift of three scaffolds upon
BRACO19 binding (i.e., an increase of population of parallel scaffold, a decrease of populations of
antiparallel and/or hybrid scaffold). This hypothesis appears to be consistent with the fact that
BRACO19 was specifically designed based on the structural requirements of the parallel scaffold
and has since proven effective against a variety of cancer cell lines as well as toward a number of
scaffolds. In addition, this binding mode is only slightly more favorable than BRACO19s binding
to the duplex, explaining the low binding selectivity of BRACO19 to G-quadruplexes over duplex
DNA. Our detailed analysis suggests that BRACO190 s groove binding mode may not be stable
enough to maintain a prolonged binding event and that the groove binding mode may function
as an intermediate state preceding a more energetically favorable end stacking pose; base flipping
played an important role in enhancing binding interactions, an integral feature of an induced fit
binding mechanism.
Keywords: BRACO19; human telomeric G-quadruplexes; molecular dynamics binding simulations

1. Introduction
The first therapeutically important G-quadruplex sequence was located in the single stranded 30
overhang of human telomeric DNA [1,2], and contains numerous repeats of d(TTAGGG)n sequences
capped by Shelterin complexes [3–6]. The Shelterin complexes provide protection against nuclease
attacks, chromosomal end-to-end fusion and gene erosion at cell divisions [7]. After each cell replication
the telomere truncates by 50–200 base pairs, when the telomere is exhausted and the Hayflick limit
is reached, cell senescence and apoptosis are triggered [8,9]. In cancer cells, a reverse transcriptase
telomerase adds nucleotides to the telomere immortalizing the cells [10,11]. Telomerase is found
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to be overexpressed in 80–85% of tumor cells underscoring why telomerase inhibition is a logical
therapeutic approach in cancer treatment. Despite the potential of this approach challenges include:
(i) a time delay in which the telomere length needs to be established for the ultimate apoptosis
trigger [8,12,13] and (ii) that studies suggest an alternate mechanism for telomerase maintenance
might be activated upon telomerase inhibition [14–16]. However, it has been reported that the
telomere cannot be hybridized by telomerase when the single stranded 30 overhang folds into a
G-quadruplex [17], instead the telomeric G-quadruplex is perceived as DNA damage and stimulates
cell level apoptosis [2,18]. Accentuating how a ligand that stabilizes the telomeric G-quadruplex can
be an efficacious anti-cancer therapy.
Extensive research has been performed that show G-quadruplexes are highly polymorphic and
their topological fold depends on factors such as nucleic acid sequence, ions and the presence of
small molecules [19–23]. Though studied for decades, the most biologically relevant topological fold
of human telomeric G-quadruplex remains an elusive and controversial debate. In 1993, Wang and
Patel published the first solution structure of the human telomeric sequence d[AG3(T2AG3)3] in
Na+ containing solution which adopts anti-parallel topology (PDB ID: 143D); formally referred to
as 3(-lwd+ln) [24]. In 2002, Parkinson and coworkers published a K+ containing crystal structure
of the human telomeric DNA in a parallel topological fold, referred to as 3(-p-p-p) in Table 1 using
the nomenclature recently described by Dvorkin et al. [25] (PDB ID: 1KF1) [26]. The parallel crystal
structure published by Parkinson and coworkers was different from the preceding studies which
reported the DNA in an anti-parallel topological fold in Na+ containing solution [24,27,28]. In the years
following, experiments providing evidence for both topological folds continued to publish. The parallel
topological fold was suggested the most biologically relevant form in K+ containing crystal because
the polymorphism of the G-quadruplex structure was lost in 40% PEG or 50% ethanol solutions,
ie. dehydrated solutions [29]. Heddi and Phan studied the human telomeric sequence under crowded
conditions with NMR, using the same dehydrating crowding agents used in X-ray crystallography,
and found that the parallel conformation predominated [30]. In contrast, solution studies using
NMR and 125I-radioprobing were also published providing evidence for the anti-parallel topology
in both K+ and Na+ containing solution, several of which reported the parallel and anti-parallel
topologies coexist under both ionic conditions [31–34]. Not long after Parkinson and coworker’s
parallel crystal structure was published solution studies began to identify additional topological folds
for the human telomeric DNA [35–40]. Yang and coworkers [41] showed the same sequence with two
additional naturally occurring adenine residues at the 50 and 30 termini in K+ solution folds into a
hybrid scaffold in 2007 (PDB ID: 2HY9), formally referred to as 3(-p-lw-ln) in Table 1. The skepticism
regarding the predominating topology in physiological conditions has led to studies suggesting that
rather than the parallel topology, both the anti-parallel [34,35,42] and hybrid [37,41] forms are most
physiologically relevant.
Table 1. Molecular dynamics simulations.
System ID

DNA

No. of
Ligand

No. of
Run

Drug Initial
State

NPT eq.
(ns)

NVT (ns)

Total
Time (µs)

1
2
3
4
5
6
7
8
9

n/a
Duplex(d([GC]10 )2 )
3(-p-p-p) (1KF1)
3(-lwd+ln) (143D)
3(-p-lw-ln) (2HY9)
Duplex(d([GC]10 )2 )
3(-p-p-p) (1KF1)
3(-lwd+ln) (143D)
3(-p-lw-ln) (2HY9)

1
0
0
0
0
1
1
1
1

2
2
2
2
2
9+1
8+2
9+1
9+1

Free
Free
Free
Free
Free
Free
Free
Free
Free

1
1
1
1
1
1
1
1
1

500
500
500
500
500
500 + 2000
500 + 2000
500 + 2000
500 + 2000

1
1
1
1
1
6.5
8.0
6.5
6.5

The contradicting results being published gave rise to discussion regarding the experimental
accuracy of using dehydrating crowding agents like PEG to report the structure of the highly flexible
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and dynamic DNA G-quadruplex. In 2005, Li and coworkers published work that directly refuted
the biological relevance of the parallel stranded crystal structure of the human telomeric DNA
G-quadruplex reported by Parkinson and coworkers delineating that by using certain dehydrating
solvents, like PEG, crowding conditions are not being mimicked but rather conditions of extreme
water depletion that is misrepresentative of physiological conditions [35]. Using acetyl nitrile,
a non-dehydrating crowding agent, Miller et al. proposed the structure of the human telomeric
sequence was not identical to the structure published in crystalline state, supporting the role of
hydration in the stability and conformation of this human telomeric sequence. Using Ficoll and
Xenopus laevis egg extract compared to PEG, Hansel and coworkers (doi:10.1093/nar/gkr174) suggested
the parallel scaffold is not the preferred topology under physiological conditions, but rather the parallel,
anti-parallel, and hybrid topologies co-exist under native conditions. Stating that in Ficoll or cellular
extracts, the more predominate conformations in the co-existing equilibrium mixture are likely the
anti-parallel and/or the hybrid topologies. Analyzing the studies overall, evidence suggests that this
sequence forms multiple intramolecular G-quadruplex scaffolds in K+ solution and the intramolecular
parallel G-quadruplex observed in the K+-containing crystal appears unlikely to be the major form in
K+-containing solution [32,33,43–47]. Given the broad range of evidence to support each of the three
scaffolds and without evidence to rule out the predominance of any of the reported scaffolds, one of
each the parallel, anti-parallel, and hybrid topological folds were modeled in this study.
Based on structural requirements of the parallel-stranded telomeric G-quadruplex binding
site, BRACO19, a tri-substituted acridine (Figure 1), was rationally designed with computer
modelling [48,49] and has since been one of the most widely studied G-quadruplex binders. BRACO19
has been reported to inhibit telomerase which causes telomere shortening [50]; its experimental
in-vivo activity against a variety of cell lines is reported (Table 2). Furthermore, BRACO19 have
been shown effective in anti-viral, and anti-parasitic treatments. BRACO19 also demonstrates broad
anti-viral activity by stabilizing the G-quadruplexes found in pro-viral genomes [51] such as the viruses:
HIV-1, HSV-1, EBV, HHV-6, and HBV [52]. BRACO19 also showed in vitro anti-parasitic activity in
bloodstream forms of T. brucei brucei, against promastigotes of L. major, against P. falciparum [53],
as well as against a human non-tumoral lung cell line (MRC-5) [54]. A major factor that has
prevented BRACO19 from clinical usage is a low selectivity towards G-quadruplex over duplex
DNA (K_quad/K_dup = 40-fold, K: ligand binding constant) [49], which has the potential to cause
reverse effects. To achieve higher selectivity (e.g., 105 -fold), better understanding of the binding nature
of BRACO19 with DNA G-quadruplex and duplex DNA is required.
Table 2. In vivo activity of BRACO19 against various cancer cell lines.
Cell Lines

Tissue Type

IC50

References

MCF7
A549
DU145
HT-29
HGC-27
A2780
WI-38
IMR90
U87
U251
SHG-44
UXF1138L
CH1
SKOV3
CLL
AML
–

Breast cancer (human)
Lung cancer (human)
Prostate cancer (human)
Colon cancer (human)
Gastric carcinoma
Ovarian cancer (human)
Lung fibroblast (human)
Lung fibroblast (human)
Glioblastoma (human)
Glioblastoma (human)
Glioma (human)
Uterus carcinoma (human)
Lymphoma (mouse)
Ovarian cancer (human)
Chronic lymphocytic leukemia
Acute myeloid leukemia
Prolymphocytic leukemia

2.5 µM
2.4 µM
2.3 µM
2.7 µM
2.6 µM
2.5 µM
10.7 µM
>25 µM
1.45 µM
1.55 µM
2.5 µM
2.5 µM
10.1 µM
13.0 µM
80 µM
80 µM
80 µM

[55,56]
[55,57]
[55,58]
[55,59]
[55,60]
[55,61]
[55,62]
[55,63]
[64,65]
[64]
[64]
[66]
[67]
[67,68]
[69,70]
[70]
[70]
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Figure 1. Chemical structure of BRACO19.
Figure 1. Chemical structure of BRACO19.

Despite the high interest of BRACO19 in complex with biologically relevant single stranded
Despite the high interest of BRACO19 in complex with biologically relevant single stranded
intramolecular DNA G-quadruplex formed by one chain (e.g., d(AGGGTTAGGGTTAGGGT TAGGG)),
intramolecular DNA G-quadruplex formed by one chain (e.g., d(AGGGTTAGGGTTAGGGT
there is no high-resolution structure of BRACO19 binding to the antiparallel and the hybrid topology.
TAGGG)), there is no high-resolution structure of BRACO19 binding to the antiparallel and the
The only high-resolution structure available is a bimolecular parallel G-quadruplex in complex with
hybrid topology. The only high-resolution structure available is a bimolecular parallel G-quadruplex
BRACO19 (PDB ID: 3CE5), where the intermolecular G-quadruplex is formed from two 12 residue
in complex with BRACO19 (PDB ID: 3CE5), where the intermolecular G-quadruplex is formed from
chains (i.e., d(TAGGGTTAGGGT)) [71]. Because bimolecular (12mer) or intramolecular (22mer) adopt
two 12 residue chains (i.e., d(TAGGGTTAGGGT)) [71]. Because bimolecular (12mer) or
the same parallel topology, suggested by Parkinson et al. [26] and later confirmed by Phan et al. [30] in
intramolecular (22mer) adopt the same parallel topology, suggested by Parkinson et al. [26] and later
both Na+ or K+ in solution under crowded conditions, this crystal structure provides the following
confirmed by Phan et al. [30] in both Na+ or K+ in solution under crowded conditions, this crystal
invaluable interaction insights: BRACO19 interacts asymmetrically with the guanine bases of the
structure provides the following invaluable interaction insights: BRACO19 interacts asymmetrically
intermolecular G-quadruplex through π–π interactions and the nitrogen atom of the acridine ring
with the guanine bases of the intermolecular G-quadruplex through π–π0 interactions
and the
aligns with the K+ cations within the ion pore. Nonetheless
the additional 5 and 30 residues at the
+
nitrogen atom of the acridine ring aligns with the K cations within the ion pore. Nonetheless the
two ends could introduce artifacts when comparing the BRACO19 binding modes on the biologically
additional 5′ and 3′ residues at the two ends could introduce artifacts when comparing the BRACO19
relevant unimolecular parallel scaffold formed the single stranded telomeric sequence. To remove the
binding modes on the biologically relevant unimolecular parallel scaffold formed the single stranded
artifacts, we used another crystal structure (PDB ID: 1KF1) containing the apo form of the parallel
telomeric sequence. To remove the artifacts, we used another crystal structure (PDB ID: 1KF1)
intramolecular telomeric G-quadruplex in our BRACO19 binding studies. Furthermore, because
containing the apo form of the parallel intramolecular telomeric G-quadruplex in our BRACO19
the most biologically relevant form may not be the parallel form, the binding of BRACO19 to the
binding studies. Furthermore, because the most biologically relevant form may not be the parallel
antiparallel and the hybrid form are required to better understand its biology relevant binding mode
form, the binding of BRACO19 to the antiparallel and the hybrid form are required to better
leading to its anti-cancer properties [19,35].
understand its biology relevant binding mode leading to its anti-cancer properties [19,35].
Computationally, molecular docking and molecular dynamics (MD) stability simulations have
Computationally, molecular docking and molecular dynamics (MD) stability simulations have
been widely used in studying G-quadruplexes in complex with BRACO19 and other ligands.
been widely used in studying G-quadruplexes in complex with BRACO19 and other ligands. Haider
Haider and Neidle studied the stability of human telomeric DNA G-quadruplex repeats using molecular
and Neidle studied the stability of human telomeric DNA G-quadruplex repeats using molecular
models of dimer and tetramer telomeric G-quadruplex repeats followed by MD simulations [72].
models of dimer and tetramer telomeric G-quadruplex repeats followed by MD simulations [72].
Collie et al. used MD simulation to study the stability of BRACO19 and three naphthalene diimide
Collie et al. used MD simulation to study the stability of BRACO19 and three naphthalene diimide
ligands in complex with a parallel stranded telomeric DNA G-quadruplex (PDB ID: 1KF1), using the
ligands in complex with a parallel stranded telomeric DNA G-quadruplex (PDB ID: 1KF1), using the
solved binding pose from the crystal structure of BRACO19 (PDB ID: 3CE5) as a starting point [73].
solved binding pose from the crystal structure of BRACO19 (PDB ID: 3CE5) as a starting point [73].
Xu et al. [74] used molecular docking to study a propeller-shaped trinuclear PtIIII complex with the
Xu et al. [74] used molecular docking to study a propeller-shaped trinuclear Pt complex with the
anti-parallel G4 (PDB ID: 143D) and showed binding to the major groove closest to the 50 end. Moore et al.
anti-parallel G4 (PDB ID: 143D) and showed binding to the major groove closest to the 5′ end. Moore
conducted MD simulations to investigate the structure-activity relationships of BRACO19 analogs
et al. conducted MD simulations to investigate the structure-activity relationships of BRACO19
and a modeled 22mer parallel G-quadruplex [75]. Hou et al. revealed hydrogen bonds to be the
analogs and a modeled 22mer parallel G-quadruplex [75]. Hou et al. revealed hydrogen bonds to be
major contributor of stability for the G-quadruplex and ligand-quadruplex complex by conducting
the major contributor of stability for the G-quadruplex and ligand-quadruplex complex by
stability simulations on G-quadruplex-ligand complexes involving BRACO19 and 5 other ligands [76].
conducting stability simulations on G-quadruplex-ligand complexes involving BRACO19 and 5 other
Dhamodharan et al. suggested end-stacking as the favored binding mode after docking bis-quinolinium
ligands [76]. Dhamodharan et al. suggested end-stacking as the favored binding mode after docking
and bis-pyridinium derivatives of 1,8-naphthyridine onto anti-parallel G-quadruplex and further
bis-quinolinium and bis-pyridinium derivatives of 1,8-naphthyridine onto anti-parallel Gconducting MD simulations [77]. Jain et al. reported that both end-stacking and groove-binding
quadruplex and further conducting MD simulations [77]. Jain et al. reported that both end-stacking
were favored after docking dimeric 1,3-phenylene-bis(piperazinyl benzimidazole)s to a 22mer parallel
and groove-binding were favored after docking dimeric 1,3-phenylene-bis(piperazinyl
G-quadruplex followed by MD simulations [78]. Ungvarsky et al. characterized the binding poses
benzimidazole)s to a 22mer parallel G-quadruplex followed by MD simulations [78]. Ungvarsky et
of a novel set of BRACO19 derivatives to the human telomeric parallel G-quadruplex by successfully
al. characterized the binding poses of a novel set of BRACO19 derivatives to the human telomeric
parallel G-quadruplex by successfully employing docking and MD simulations [79]. Also,
Diveshkumar et al. conducted a docking and MD simulation study on various G-quadruplexes (PDB
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employing docking and MD simulations [79]. Also, Diveshkumar et al. conducted a docking and
MD simulation
Molecules 2019,study
24, x on various G-quadruplexes (PDB IDs: 2L7V, 2O3M, 1KF1, 143D, and 2MB3)
5 of 25 and
identified indolyl, methylene-indanone scaffolds which demonstrate selectivity towards parallel promoter
IDs: 2L7V, 2O3M,
1KF1, 143D,
and quadruplex
2MB3) and identified
methylene-indanone
scaffolds
G-quadruplexes
over telomeric
DNA
or duplexindolyl,
DNA [80].
Nonetheless, these
stability
which
demonstrate
selectivity
towards
parallel
promoter
G-quadruplexes
over
telomeric
simulations do not provide detailed information on the binding pathway and low selectivity. DNA
quadruplex or duplex DNA [80]. Nonetheless, these stability simulations do not provide detailed
Deng et al. showed that using two statistical mechanics-based free energy simulation methods
information on the binding pathway and low selectivity.
(potential of mean force and double-decoupling method) allows for binding affinity calculations at various
Deng et al. showed that using two statistical mechanics-based free energy simulation methods
binding
sites inofthe
c-MYC
which is inmethod)
agreement
with
findings
[81]. The
(potential
mean
forceG-quadruplex
and double-decoupling
allows
forexperimental
binding affinity
calculations
at use
of µs-scale
simulations
with
the
latest
AMBER
force
fields
have
shown
to
provide
a
good
evaluation
of
various binding sites in the c-MYC G-quadruplex which is in agreement with experimental findings
the loop
conformation
of
the
G-quadruplexes
[58].
Using
µs-scale
simulations
with
the
latest
AMBER
[81]. The use of µs-scale simulations with the latest AMBER force fields have shown to provide a
of the loop
conformation
of the G-quadruplexes
[58]. Using
µs-scale
simulations
forcegood
fieldsevaluation
in our previous
work
produced detailed
and experimentally
verified
predictions
[82–86].
with
the latest
AMBER
fields
our previous
work produced
detailedOL15
and experimentally
In this
work,
by using
freeforce
ligand
MDin binding
simulations
with AMBER
DNA and GAFF2
verified
[82–86].1),
In we
this were
work,able
by using
free ligand
MD binding
withto
AMBER
ligand
force predictions
fields [84] (Table
to predict
a binding
modesimulations
of BRACO19
the double
OL15
DNA
and
GAFF2
ligand
force
fields
[84]
(Table
1),
we
were
able
to
predict
a
binding
mode
of ID:
stranded parallel telomeric G-quadruplex that is consistent with the crystal complex structure (PDB
BRACO19 to the double stranded parallel telomeric G-quadruplex that is consistent with the crystal
3CE5). Furthermore, the binding modes and the ligand binding pathways were characterized in detail.
complex structure (PDB ID: 3CE5). Furthermore, the binding modes and the ligand binding pathways
We extended our free ligand MD simulations to characterize the binding pathway of BRACO19 to the
were characterized in detail. We extended our free ligand MD simulations to characterize the binding
parallel,
anti-parallel,
hybrid
DNA
G-quadruplexes
duplex
(Figure 2). and
Major
binding
pathway
of BRACO19
to the
parallel,
anti-parallel,and
hybrid
DNADNA
G-quadruplexes
duplex
DNAposes,
(top binding,
bottom
binding
and
groove
binding)
were
identified
and
detailed
binding
pathways
(Figure 2). Major binding poses, (top binding, bottom binding and groove binding) were identified were
characterized.
The
dynamic
and energetic
properties The
of the
three major
bindingproperties
modes were
and detailed
binding
pathways
were characterized.
dynamic
and energetic
of thethoroughly
three
major
binding
modes
thoroughly
studied.
We of
suggest
that the
similar pose
binding
energy
of the
studied.
We
suggest
that were
the similar
binding
energy
the groove
binding
to the
duplex
and of
groove
binding
pose
to
the
duplex
and
of
the
top
stacking
pose
to
the
parallel
G-quadruplexes
may
the top stacking pose to the parallel G-quadruplexes may be responsible for the low selectivity (40-fold)
be responsible
the low
selectivity
BRACO19.
This modification
study may provide
insight into
theother
of BRACO19.
Thisfor
study
may
provide(40-fold)
insight of
into
the further
of BRACO19
and
further
modification
of
BRACO19
and
other
G-quadruplex
binders
to
enhance
overall
selectivity
and
G-quadruplex binders to enhance overall selectivity and efficacy.
efficacy.

A

B

C

Figure 2. Cont.

Molecules 2019, 24, 1010
Molecules 2019, 24, x

6 of 26
6 of 25

D

Figure 2. Structure of human telomeric duplex DNA (A), human telomeric parallel DNA G-quadruplex
Figure 2. Structure of human telomeric duplex DNA (A), human telomeric parallel DNA G(PDB ID: 1KF1) 3(-p-p-p) (B), human telomeric anti-parallel DNA G-quadruplex (PDB ID: 143D)
quadruplex (PDB ID: 1KF1) 3(-p-p-p) (B), human telomeric anti-parallel DNA G-quadruplex (PDB ID:0
3(-lwd+ln) (C), and human telomeric hybrid DNA quadruplex (PDB ID: 2HY9) 3(-p-lw-ln) (D). 5 and
143D) 3(-lwd+ln) (C), and human telomeric hybrid DNA quadruplex (PDB ID: 2HY9) 3(-p-lw-ln) (D).
30 of the
DNA chain are indicated by a red and blue ball, respectively.
5′ and 3′ of the DNA chain are indicated by a red and blue ball, respectively.

2. Results

2. Results

2.1. Multiple Drug Binding Modes Were Observed in Free Ligand Binding Simulations
2.1. Multiple Drug Binding Modes Were Observed in Free Ligand Binding Simulations

Starting
from
an an
unbound
wesimulated
simulated
ns production
runs
each The
system.
Starting
from
unboundstate,
state, we
tenten
500500
ns production
runs for
eachfor
system.
The convergence
the
binding
simulations
was confirmed
(see thesection),
method
section),plot
a sampling
convergence ofofthe
binding
simulations
was confirmed
(see the method
a sampling
was
plot was
generated
tothe
trace
the position
of one
atom of BRACO19
theentire
length
of the entire
generated
to trace
position
of one atom
of BRACO19
through the through
length of the
simulation
periodperiod
for eachfor
system
The last
snapshots
each simulated
trajectory
of thetrajectory
duplex- of
simulation
each(Figure
systemS31).
(Figure
S31).
The lastfrom
snapshots
from each
simulated
BRACO19
system
is
listed
in
Figure
S10
and
indicate
the
stability
of
the
DNA
structures
where
the
the duplex-BRACO19 system is listed in Figure S10 and indicate the stability of the DNA structures
base
pairing
was
maintained.
The
last
snapshots
of
all
the
simulated
trajectories
of
the
G-quadruplexwhere the base pairing was maintained. The last snapshots of all the simulated trajectories of
ligand systems are listed in Figures S11–S13 and indicate the stability of the G-quadruplex structures
the G-quadruplex-ligand
systems are listed in Figures S11–S13 and indicate the stability of the
where the G-tetrads were maintained. The major binding modes of BRACO19 in complex with the
G-quadruplex structures where the G-tetrads were maintained. The major binding modes of BRACO19
parallel, anti-parallel and hybrid telomeric DNA is presented in Figure 3. Multiple binding sites were
in complex
with the parallel, anti-parallel and hybrid telomeric DNA is presented in Figure 3.
observed in the ten duplex DNA-BRACO19 trajectories. The clustering analysis described in the
Multiple
binding
sites
were
observed
in the ten the
duplex
DNA-BRACO19
trajectories.
clustering
methods
section
was
employed
to categorize
stable
complexes that were
extractedThe
from
the
analysis
described
the methods
was
employed
to categorize
stable complexes
trajectories
into in
structural
families.section
By setting
a threshold
of 1%
population, the
14 structural
families of that
were complexes
extracted were
fromidentified
the trajectories
setting
a threshold
of 1%
population,
(Figure into
S14). structural
These eightfamilies.
structuralBy
families
were
further merged
into
three
binding
modes:
groove
binding,
top
stacking
and
bottom
stacking.
Binding
to
the
groove
of
the
14 structural families of complexes were identified (Figure S14). These eight structural families
for 81%
of the
total population.
Additionally,
endtop
stacking
to theand
top bottom
of the duplex
were duplex
furtheraccounted
merged into
three
binding
modes: groove
binding,
stacking
stacking.
accounted
4% and
to the bottom
of 81%
the duplex
2% of the total
population end
Binding
to the for
groove
of end
the stacking
duplex accounted
for
of themade
total up
population.
Additionally,
(Figure S14). Three binding modes were observed in the ten parallel G-quadruplex DNA-BRACO19
stacking
to the top of the duplex accounted for 4% and end stacking to the bottom of the duplex made
trajectories. The clustering analysis was employed to categorize the stable complexes that were
up 2% of the total population (Figure S14). Three binding modes were observed in the ten parallel
extracted from the trajectories into 11 structural families (Figure S15). The three binding modes
G-quadruplex
DNA-BRACO19 trajectories. The clustering analysis was employed to categorize
observed were: top stacking, bottom stacking and groove binding. Top stacking to the parallel Gthe stable
complexes
that wereforextracted
from
the trajectories
families
(Figure
quadruplex DNA accounted
28%, bottom
stacking
accounted forinto
41%11
andstructural
groove binding
for 29%
S15). of
The
three
binding
modes
observed
were:
top
stacking,
bottom
stacking
and
groove
binding.
the total population (Figure S15). Multiple binding sites were observed in the ten anti-parallel DNA
Top stacking
to the parallel G-quadruplex
accounted
bottom
stacking accounted
G-quadruplex-BRACO19
trajectories. The DNA
clustering
analysisfor
was28%,
employed
to categorize
the stable for
complexes
were extracted
these
trajectories
into(Figure
9 structural
(Figure
S16). sites
Threewere
41% and
groovethat
binding
for 29% from
of the
total
population
S15).families
Multiple
binding
binding
modes
observed:DNA
top, bottom
and groove binding. Bottom
binding
to the
anti-parallel
observed
in the
ten were
anti-parallel
G-quadruplex-BRACO19
trajectories.
The
clustering
analysis
G-quadruplex
DNA
accounted
for
46%,
top
binding
for
25%
and
groove
binding
for
40%
of
the
total
was employed to categorize the stable complexes that were extracted from these trajectories into 9
population (Figure S16). Multiple binding sites were observed in the ten hybrid G-quadruplex DNAstructural
families (Figure S16). Three binding modes were observed: top, bottom and groove binding.
BRACO19 trajectories. The same clustering analysis was employed to categorize the stable complexes
Bottom binding to the anti-parallel G-quadruplex DNA accounted for 46%, top binding for 25% and
that were extracted from these trajectories into 11 structural families (Figure S17). Three binding
groove
binding
40% oftop,
the groove
total population
Multiple
sites G-quadruplex
were observed in
modes
werefor
observed:
and bottom(Figure
binding.S16).
Groove
bindingbinding
to the hybrid
the ten
hybrid
G-quadruplex
DNA-BRACO19
trajectories.
The
same
clustering
analysis
was employed
DNA accounted for 43%, top binding for 33%, and bottom binding for 20% of the total population
to categorize
the stable
complexesinteraction
that were diagrams
extractedoffrom
these trajectories
intoeach
11 structural
families
(Figure S17).
Two dimensional
BRACO19
in complex with
DNA system,
(Figure
Threebinding
binding
modes
were observed:
top, groove
and bottom
Groove binding to
in S17).
each major
pose,
is available
in the supporting
document
(Figurebinding.
S18).
the hybrid G-quadruplex DNA accounted for 43%, top binding for 33%, and bottom binding for 20% of
the total population (Figure S17). Two dimensional interaction diagrams of BRACO19 in complex with
each DNA system, in each major binding pose, is available in the supporting document (Figure S18).
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(D) Hybrid GQuadruplex

(C) Anti-parallel GQuadruplex

(B) Parallel GQuadruplex

(A) DNA Duplex
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Figure
3. The
major
modesofofBRACO19
BRACO19
in complex
the human
telomeric
Figure
3. The
majorbinding
binding modes
in complex
with with
the human
telomeric
DNA. (A)DNA.
(A) Duplex;
(C)Anti-parallel
Anti-parallel
human
telomeric
G-quadruplex;
(D) Hybrid
Duplex; (B)
(B) Parallel
Parallel G-quadruplex;
G-quadruplex; (C)
human
telomeric
G-quadruplex;
(D) Hybrid
human
telomeric
G-quadruplex. (A–D)
(A–D) Top binding
binding
(middle)
and and
groove
human
telomeric
G-quadruplex.
binding(left),
(left),Bottom
Bottom
binding
(middle)
groove
binding
(right);
5′ end
and
endare
arerepresented
represented by
ball
respectively.
binding
(right);
50 end
and
30 3′
end
by the
thered
redand
andblue
blue
ball
respectively.

2.2. VDW
Interaction
Contributes
Energyand
andinin
Ranking
Binding
2.2. VDW
Interaction
ContributesMost
Mosttotothe
the Total
Total Binding
Binding Energy
Ranking
the the
Binding
PosesPoses
for for
Each Each
DNA-Ligand
System
DNA-Ligand
System
MM-GBSA
bindingenergy
energy calculations
calculations were
out,out,
as depicted
in methods
section, section,
to
MM-GBSA
binding
werecarried
carried
as depicted
in methods
examine
the
relative
binding
affinities
of
the
major
binding
modes
of
BRACO19
with
respect
to
the
to examine the relative binding affinities of the major binding modes of BRACO19 with respect
in in
Table
S1.S1.
The
most
favorable
binding
energy
for the
to theDNA
DNAand
andsummarized
summarized
Table
The
most
favorable
binding
energy
for duplex-BRACO19
the duplex-BRACO19
complex was the groove binding mode (−61.7 ± 8.0 kcal/mol), followed by the bottom stacking mode
complex was the groove binding mode (−61.7 ± 8.0 kcal/mol), followed by the bottom stacking mode
(−34.6 ± 5.7 kcal/mol) and the top stacking mode (−33.7 ± 5.3 kcal/mol). VDW packing, responsible for
(−34.6 ± 5.7 kcal/mol) and the top stacking mode (−33.7 ± 5.3 kcal/mol). VDW packing, responsible
the VDW energy contribution, was the primary contributor to the binding energy of the three modes.
for the
VDW energy contribution, was the primary contributor to the binding energy of the three
BRACO19 bound to parallel G-quadruplex DNA in three binding pose where top stacking (−62.3 ±
modes.
BRACO19
bound
to parallel
G-quadruplex
three binding
pose where
top
stacking
4.5 kcal/mol)
was
the most
energetically
favorable, DNA
closelyin
followed
by the bottom
binding
mode
(−62.3
± 4.5
kcal/mol)
was
the
most binding
energetically
closely
by theofbottom
binding
(−61.8
± 1.5
kcal/mol),
and
groove
(−37.6 favorable,
± 7.2 kcal/mol)
wasfollowed
the least stable
the three.
modeBRACO19
(−61.8 ±bound
1.5 kcal/mol),
and groove
binding (−37.6
kcal/mol)
thewhere
least stable
to the anti-parallel
G-quadruplex
DNA±in7.2three
bindingwas
poses
bottomof the
(−53.9bound
± 5.8 kcal/mol)
was the most
stable of the three,
binding
exhibiting
a binding
three.binding
BRACO19
to the anti-parallel
G-quadruplex
DNAgroove
in three
binding
poses where
bottom
energy
of
−43.1
±
7.2
kcal/mol
and
top
binding
had
the
lowest
binding
energy
(−42.8
±
4.1kcal/mol).
binding (−53.9 ± 5.8 kcal/mol) was the most stable of the three, groove binding exhibiting a binding
energy of −43.1 ± 7.2 kcal/mol and top binding had the lowest binding energy (−42.8 ± 4.1kcal/mol).
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x
BRACO19
bound
to the hybrid G-quadruplex DNA in three binding poses 8 of
as25 well.
Top binding (−40.5 ± 5.4 kcal/mol) was the most stable of the three, followed by groove binding
BRACO19 bound to the hybrid G-quadruplex DNA in three binding poses as well. Top binding
(−35.7 ± 5.1 kcal/mol) and bottom binding (−29.0 ± 12.9 kcal/mol).

(−40.5 ± 5.4 kcal/mol) was the most stable of the three, followed by groove binding (−35.7 ± 5.1
kcal/mol) and
bottom
12.9 kcal/mol).
2.3. BRACO19
Binds
to thebinding
Groove (−29.0
of the ±Duplex
DNA, without Inducing Appreciable DNA

Structure Fluctuation

2.3. BRACO19 Binds to the Groove of the Duplex DNA, without Inducing Appreciable DNA Structure

The
representative trajectories for the three major binding modes of BRACO19 to the human
Fluctuation
telomericThe
duplex
DNA are trajectories
characterized
in three
Figure
4 and
Figure
S19. of
In BRACO19
all ten binding
representative
for the
major
binding
modes
to the trajectories,
human
the DNA
showed
low
structural
fluctuation
with
a
RMSD
of
2.4
Å
(Figure
S2)
where
the hydrogen
telomeric duplex DNA are characterized in Figure 4 and Figure S19. In all ten binding trajectories,
bondsthe
between
the base
were fluctuation
maintained.
In athe
representative
trajectory
of BRACO19
binding
DNA showed
lowpairs
structural
with
RMSD
of 2.4 Å (Figure
S2) where
the hydrogen
to thebonds
groove
of thethe
human
telomeric
duplex DNA
in Figure
4, an initial
interaction
was binding
observed as
between
base pairs
were maintained.
In the
representative
trajectory
of BRACO19
groove
of the
human
telomeric
duplex
DNA inat
Figure
4, an
initialwas
interaction
was observed
as the
early to
asthe
3 ns
and the
final
binding
pose was
achieved
~14 ns
which
maintained
throughout
early as
ns and
the finalThe
binding
posefluctuation
was achieved
~14five
ns which
maintained
throughout
remainder
of3the
trajectory.
limited
inatthe
order was
parameters
explained
thethe
limited
remainder
of the trajectory.
limited fluctuation
in theoffive
order parameters
explained
the limited
structural
dynamics.
The otherThe
representative
trajectory
BRACO19
groove binding
(Figure
S19) also
structural dynamics. The other representative trajectory of BRACO19 groove binding (Figure S19)
exhibited rapid binding and limited dynamics.
also exhibited rapid binding and limited dynamics.

02 ns

11 ns

275 ns

837 ns

1333 ns

2000 ns

Figure
A representativegroove
groovebinding
binding trajectory
trajectory ofofthe
DNA.
(Top)
Representative
Figure
4. A4. representative
theduplex
duplex
DNA.
(Top)
Representative
structures
with
time
annotation.
5′
and
3′
are
indicated
by
a
red
and
blue
ball,
respectively.
0
0
structures with time annotation. 5 and 3 are indicated by a red and blue ball, (Bottom)
respectively.
receptor (red) and ligand (black) RMSD relative to the original crystal pose, center-to-center distance
(Bottom) receptor (red) and ligand (black) RMSD relative to the original crystal pose, center-to-center
and MM-GBSA binding energy (ΔG) (cf. methods section for definition).
distance and MM-GBSA binding energy (∆G) (cf. methods section for definition).

2.4. Groove
Binding
of BRACO19
may
Intermediate State
Mode
of the
G2.4. Groove
Binding
of BRACO19
may
bebeananIntermediate
Statefor
forthe
thetop
topStacking
Stacking
Mode
of Parallel
the
Quadruplex
Parallel G-Quadruplex

The representative trajectories for the two major binding modes of BRACO19 to the parallel human
telomeric G-quadruplex DNA are characterized in Figure 5 and Figure S20 (the top stacking mode)
and Figure S21 (the bottom stacking mode). In all ten binding trajectories, the DNA showed low
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The representative trajectories for the two major binding modes of BRACO19 to the parallel human

structural
fluctuation
with RMSD
Å (Figure S4)
and the
hydrogen
bonds
the
three G-tetrads
telomeric
G-quadruplex
DNAof
are2.4
characterized
in Figure
5 and
Figure S20
(thein
top
stacking
mode) andwere
maintained.
In
the
representative
trajectory
of
BRACO19
binding
to
the
top
of
the
human
telomeric
parallel
Figure S21 (the bottom stacking mode). In all ten binding trajectories, the DNA showed low structural
fluctuation
with
2.4 initial
Å (Figure
S4) andwas
the observed
hydrogenas
bonds
three
G-tetrads
were
G-quadruplex
DNA
inRMSD
Figureof
5, an
interaction
earlyin
asthe
2 ns.
BRACO19
underwent
In the representative
trajectory
of BRACO19
binding pose
to thewas
top of
the human
severalmaintained.
top pose adjustments
until ~750
ns when
the final binding
achieved
andtelomeric
maintained
parallel
in Figure 5,Despite
an initial
interaction
wasofobserved
as early
2 ns. BRACO19
throughout
theG-quadruplex
remainder ofDNA
the trajectory.
the
repositions
BRACO19
in theasearly
portion of the
underwent several top pose adjustments until ~750 ns when the final binding pose was achieved and
simulation, there were limited fluctuations in the order parameters. The other representative trajectory of
maintained throughout the remainder of the trajectory. Despite the repositions of BRACO19 in the early
the top stacking mode of BRACO19 binding to parallel G-quadruplex (Figure S20) also exhibited quick
portion of the simulation, there were limited fluctuations in the order parameters. The other
binding
and limited dynamics, with the early interaction to the complex at 4 ns and attaining the stable
representative trajectory of the top stacking mode of BRACO19 binding to parallel G-quadruplex
top binding
25 ns
where it
maintained
staking
pose with
repositions
until
(Figurepose
S20)atalso
exhibited
quick
binding the
andtop
limited
dynamics,
withminor
the early
interaction
to 1391
the ns
wherecomplex
it remained
for
the
length
of
the
trajectory.
The
representative
trajectory
for
the
bottom
binding
at 4 ns and attaining the stable top binding pose at 25 ns where it maintained the top staking
pose (Figure
S21)minor
achieved
the final
binding
pose
within
10 ns andfordisplayed
stability
as indicated
pose with
repositions
until
1391 ns
where
it remained
the lengthhigh
of the
trajectory.
The
trajectoryinfor
bottom
binding plot.
pose (Figure
S21) achieved
the top/bottom
final binding stacking
pose
by therepresentative
limited fluctuations
thethe
order
parameter
The binding
energy for
within
10 ns and
displayed
high
stabilitywhile
as indicated
the limited
fluctuations
the
parameter
fluctuated
between
−60
and −75
kcal/mol
groovebystacking
varied
betweenin−
35order
and −
45 kcal/mol
plot.
The
binding
energy
for
top/bottom
stacking
fluctuated
between
−60
and
−75
kcal/mol
while
groove
after attaining a stable binding pose.
stacking varied between −35 and −45 kcal/mol after attaining a stable binding pose.

A1

A1

A1

T6

T6

A1
T6

T6

0 ns

05 ns

A1

79 ns

288 ns

A1

A1

T6
T6

T6

T6
A1

367 ns

797 ns

1998 ns Top View

1998 ns Side View

Figure 5. A representative top stacking trajectory of the parallel G-quadruplex.
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Figure 5. A representative top stacking trajectory of the parallel G-quadruplex. (Top) Representative
0
(Top)
Representative
time
annotation.
30 are
a red and K
blue
ball,
+ ions
structures
with timestructures
annotation.with
5′ and
3′ are
indicated5byand
a red
andindicated
blue ball, by
respectively.
+
respectively.
K ions
are represented
yellow.
order
parameter
plotofdepicting
are represented
in yellow.
(Bottom)inAn
order (Bottom)
parameterAn
plot
depicting
number
hydrogennumber
bonds of
hydrogen
bonds
present
in first
G4G4
(green),
second
and
thirdofG4
of (Figure
the DNA
present in
first G4
(green),
second
(red) and
thirdG4
G4(red)
(blue)
tetrads
the(blue)
DNAtetrads
structure
structure
(Figure
2),
the
drug-base
dihedral
angle,
receptor
(red)
and
ligand
(black)
RMSD
relative
to the
2), the drug-base dihedral angle, receptor (red) and ligand (black) RMSD relative to the original crystal
+
+
+
+
original
crystal pose, center-to-center
distance
and(R/red)
K -K and
distance
(R/red)
and MM-GBSA
-K distance
MM-GBSA
binding
energy
pose, center-to-center
distance (R/black)
and K(R/black)
binding
energy
(∆G)section
(cf. methods
section for definition).
(ΔG) (cf.
methods
for definition).

Major
fluctuations were observed in the terminal residues, however T6 in particular is discussed
Major fluctuations were observed in the terminal residues, however T6 in particular is discussed
here
as
it
demonstrates
flipped out
outat
at15
15ns
nsand
andflipped
flippedback
back
flipped
here as it demonstrateshighest
highestfluctuation.
fluctuation. T6
T6 flipped
at at
4545
ns,ns,
flipped
outout
at at
6969
nsnsand
flipped
in
at
100
ns
and
it
finally
flipped
out
at
114
ns
and
remained
same
throughout
and flipped in at 100 ns and it finally flipped out at 114 ns and remained same throughout
thethe
rest
Thisflipping
flipping
of base
the base
is mainly
characterized
α, χ
β,(Figure
γ and χ
restofofthe
the trajectory.
trajectory. This
outout
of the
is mainly
characterized
by α, β, by
γ and
(Figure
6).
Another
example
of
BRACO19
binding
to
the
parallel
scaffold
facilitated
by
base
flipping
6). Another example of BRACO19 binding to the parallel scaffold facilitated by base flipping
is
is illustrated
in Figure
Figure S30A
S30Awhich
whichshows
showsthe
theterminal
terminalresidue
residueA1
A1clearly
clearlyflipping
flipping
outward
which
illustrated in
outward
which
0 end.
provided
adequate
G-quartet,closest
closesttotothe
the5′5end.
provided
adequatespace
spacefor
forBRACO19
BRACO19to
tobind
bind to
to the top G-quartet,

Figure
6. 6.
Histograms
torsionangles
anglesofofresidue
residueT6T6between
between
free
ligand
Figure
Histogramscomparing
comparing the
the backbone
backbone torsion
thethe
free
ligand
binding
simulation
(red)
of
the
top
stacking
mode
of
the
parallel
G-quadruplex
and
the
stability
binding simulation (red) of the top stacking mode of the parallel G-quadruplex and the stability
simulation
ofof
the
G-quadruplexwithin
withinlast
last200
200ns.ns.
simulation
thecrystal
crystalstructure
structure(black)
(black) of
of the
the parallel G-quadruplex

2.5.2.5.
BRACO19
DNA,with
withInducing
InducingDNA
DNAStructure
Structure
BRACO19Binds
Bindstotothe
theAnti-Parallel
Anti-Parallel Telomeric
Telomeric G-Quadruplex
G-Quadruplex DNA,
Fluctuation in Some Trajectories
Fluctuation in Some Trajectories
The
representative trajectories for the three major binding modes of BRACO19 to the anti-parallel
The representative trajectories for the three major binding modes of BRACO19 to the antihuman
telomeric
DNA are characterized
in Figure 7 and
Figure 7S23
(the
bottom
parallel
humanG-quadruplex
telomeric G-quadruplex
DNA are characterized
in Figure
and
Figure
S23stacking
(the
mode)
and
Figure
S22
(the
top
binding
mode).
In
all
ten
binding
trajectories,
the
DNA
showed
bottom stacking mode) and Figure S22 (the top binding mode). In all ten binding trajectories,
the
high
structural
in four
trajectories
withtrajectories
RMSD of 3.2
(FigureofS6),
hydrogen
DNA
showedfluctuation
high structural
fluctuation
in four
withÅRMSD
3.2 the
Å (Figure
S6), bonds
the
+ ions remained
+
in hydrogen
the three bonds
G-tetrads
were
maintained
and
the
distance
between
K
stable
in all
in the three G-tetrads were maintained and the distance between K ions remained
trajectories.
The
representative
trajectory
of
the
bottom
stacking
mode
of
BRACO19
(Figure
7) on
stable in all trajectories. The representative trajectory of the bottom stacking mode of BRACO19
the(Figure
human7)telomeric
anti-parallel
DNA
G-quadruplex
showed an initial
interaction
5 ns. The final
on the human
telomeric
anti-parallel
DNA G-quadruplex
showed
an initialatinteraction
at
binding
pose
was
achieved
48 ns and
was48
maintained
rest of the
5 ns. The
final
binding
posewithin
was achieved
within
ns and wasthroughout
maintained the
throughout
thetrajectory.
rest of
The limited structural dynamics were explained by the limited fluctuation in the five order parameters.
The representative trajectory for the top binding mode (Figure S22) is similar to the bottom binding
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the trajectory. The limited structural dynamics were explained by the limited fluctuation in the five

trajectories
a rapidThe
binding
and limited
fluctuation
of order
parameters
with
first
interaction
orderwith
parameters.
representative
trajectory
for the top
binding
mode (Figure
S22)
is similar
to
bottom
bindingof
trajectories
a rapid
binding
and
fluctuation
of order
with
at 5 ns the
and
attainment
the final with
binding
pose
by 55
ns.limited
The binding
energy
forparameters
bottom stacking
first interaction
at 5 ns andbetween
attainment
of the
posewhile
by 55top
ns. stacking
The binding
energy
for
and groove
binding fluctuated
−55
andfinal
−65binding
kcal/mol
varied
between
bottom
stacking
and
groove
binding
fluctuated
between
−55
and
−65
kcal/mol
while
top
stacking
−40 and −50 kcal/mol after attaining a steady binding pose.
varied between −40 and −50 kcal/mol after attaining a steady binding pose.

T5

T5

T5

01 ns

06 ns

48 ns

T5
T5
T5

409 ns

1576 ns

2000 ns

Figure Figure
7.
A
representative
stackingtrajectory
trajectory
of anti-parallel
the anti-parallel
G-quadruplex.
7. A
representative bottom
bottom stacking
of the
G-quadruplex.
(Top)
0 are indicated
Representative structures
time
annotation.
5′ and
are3indicated
by a red
blue
ball,
(Top) Representative
structureswith
with
time
annotation.
50 3′
and
by and
a red
and
blue
represented
in yellow.
(Bottom)
An order
plot depicting
respectively. K
K++ ions
ball, respectively.
ionsare
are
represented
in yellow.
(Bottom)
Anparameter
order parameter
plot number
depicting
hydrogen
bonds
present
in first
secondsecond
G4 (cyan),
G4 third
(blue),G4
fourth
G4 (black)
numberofof
hydrogen
bonds
present
in(red),
first (red),
G4 third
(cyan),
(blue),
fourthand
G4 fifth
(black)
(green) layers of the DNA structure, the drug-base dihedral angle, receptor (red) and ligand (black)
and fifth (green) layers of the DNA structure, the drug-base dihedral angle, receptor (red) and ligand
RMSD relative to the original crystal pose, center-to-center distance (R/black) and K+-K+ distance
(black) RMSD relative to the original crystal pose, center-to-center distance (R/black) and K+ -K+
(R/red) and MM-GBSA binding energy (ΔG) (cf. methods section for definition).
distance (R/red) and MM-GBSA binding energy (∆G) (cf. methods section for definition).

The dihedral angles of the G-tetrads in free ligand binding simulations indicate low fluctuations

The dihedral angles of the G-tetrads in free ligand binding simulations indicate low fluctuations
and are consistent through the binding process. Major fluctuations were observed in the terminal
and are consistent through the binding process. Major fluctuations were observed in the terminal
residues, T5 in particular is discussed here as it demonstrates highest fluctuation. Through the binding
process BRACO19s major interaction was with T5, which opened up as BRACO19 approached and at
29 ns flipped out to let BRACO19 in and flipped back at 40 ns and staying open after interacting with
BRACO19. This flipping out of the base is mainly characterized by ε and ζ (Figure 8).

residues, T5 in particular is discussed here as it demonstrates highest fluctuation. Through the
binding process BRACO19s major interaction was with T5, which opened up as BRACO19
approached and at 29 ns flipped out to let BRACO19 in and flipped back at 40 ns and staying open
after
interacting
with BRACO19. This flipping out of the base is mainly characterized by ε 12
and
ζ
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Figure 8. Histograms comparing the backbone torsion angles of residue T05 between the free ligand
Figure 8. Histograms comparing the backbone torsion angles of residue T05 between the free ligand
binding simulation (red) of the top stacking trajectory of the anti-parallel G-quadruplex and the stability
binding simulation (red) of the top stacking trajectory of the anti-parallel G-quadruplex and the
simulation of the crystal structure (black) of the anti-parallel G-quadruplex.
stability simulation of the crystal structure (black) of the anti-parallel G-quadruplex.

Another example of this base flipping for the anti-parallel topology is illustrated in Figure S30B,
Another example
of this base flipping for the anti-parallel topology is illustrated in Figure S30B,
where BRACO190 s major interaction is with base A7. As a result of BRACO190 s interaction with base
where BRACO19′s major interaction is with base A7. As a result of BRACO19′s interaction with base
A7, the base T5 flips upward allowing base A7 to flip to the outside of BRACO19 maximizing the
A7, the base T5 flips upward allowing base A7 to flip to the outside of BRACO19 maximizing the
binding interactions between the G-quadruplex and BRACO19. The base T5 remains flipped up for
binding interactions between the G-quadruplex and BRACO19. The base T5 remains flipped up for
the remainder of the trajectory and the interaction where A7 is partially intercalating BRACO19 onto
the remainder of the trajectory and the interaction where A7 is partially intercalating BRACO19 onto
the G-quadruplex is also maintained.
the G-quadruplex is also maintained.
2.6. BRACO19 Binds to the Hybrid Telomeric G-Quadruplex DNA, Inducing big DNA Structure Fluctuation
2.6.
BRACO19
Binds to the Hybrid Telomeric G-Quadruplex DNA, Inducing big DNA Structure
in Some
Trajectories
Fluctuation in Some Trajectories
The representative trajectories for the three-major binding modes of BRACO19 with respect to
The representative
trajectories
for the DNA
three-major
binding modes
of BRACO19
withS24
respect
to
the hybrid
human telomeric
G-quadruplex
are characterized
in Figure
9 and Figure
(the top
the
hybrid
human
telomeric
G-quadruplex
DNA
are
characterized
in
Figure
9
and
Figure
S24
(the
binding mode), Figure S25 (the bottom binding mode) and Figure S26 (the groove binding mode).
top
mode),
Figure
S25 (the bottom
binding
mode)
and
Figure S26
(the groove
binding
mode).
Outbinding
of the ten
binding
trajectories,
the DNA
showed
high
structural
fluctuation
in five
trajectories
Out
the ten
trajectories,
thehydrogen
DNA showed
structural
fluctuation
in maintained
five trajectories
withof
RMSD
of binding
2.9 Å (Figure
S8), the
bondshigh
in the
three G-tetrads
were
and
+
with
RMSD
of
2.9
Å
(Figure
S8),
the
hydrogen
bonds
in
the
three
G-tetrads
were
maintained
and
the distance between K ions remained stable in all trajectories. The representative trajectorythe
of
distance
between
K+ ions onto
remained
stable in
all trajectories.
The representative
trajectory
of BRACO19
BRACO19
top stacking
the hybrid
G-quadruplex
DNA
showed an initial
interaction
at 3 ns,
top
stacking
ontopose
the was
hybrid
G-quadruplex
initial interaction
at 3the
ns,rest
theoffinal
the final
binding
attained
as early asDNA
30 nsshowed
and wasan
maintained
throughout
the
binding
pose
was
attained
as
early
as
30
ns
and
was
maintained
throughout
the
rest
of
the
trajectory.
trajectory. The limited structural dynamics were explained by the limited fluctuation in the five order
The
limited The
structural
dynamics
were explained
by (Figure
the limited
fluctuation
in the (Figure
five order
parameters.
representative
trajectories
of the bottom
S25) and
groove binding
S26)
parameters.
The
representative
trajectories
of
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G-quadruplex. Bases A23 and T13 made slight adjustments in their position for the remainder of the
trajectory, whereas BRACO19 remained stably bound to the bottom of the G-quadruplex.
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3. Discussion
3. Discussion
After the discovery of the greater existence of G-quadruplexes in malignant tumors than in
After the discovery of the greater existence of G-quadruplexes in malignant tumors than in
normal tissues, the interest in G-quadruplex DNA as a target for cancer therapeutics has increased.
normal tissues, the interest in G-quadruplex DNA as a target for cancer therapeutics has increased.
BRACO19, an effective G-quadruplex stabilizing ligand, is a promising anticancer drug candidate, yet
BRACO19, an effective G-quadruplex stabilizing ligand, is a promising anticancer drug candidate,
its low preferential binding affinity (about ~40-fold) to the telomeric single-stranded G-quadruplex
yet its low preferential binding affinity (about ~40-fold) to the telomeric single-stranded GDNA over duplex DNA remains to be enhanced. There are the two lines of conflicting evidence on
quadruplex DNA over duplex DNA remains to be enhanced. There are the two lines of conflicting
the major target form of BRACO19: (1) under solution conditions with cellular extracts as crowding
evidence on the major target form of BRACO19: (1) under solution conditions with cellular extracts
agents, the more predominate conformations are likely the anti-parallel and/or the hybrid topologies.
as crowding agents, the more predominate conformations are likely the anti-parallel and/or the
(2) There is no high-resolution complex structures of BRACO19 binding to antiparallel or the hybrid
hybrid topologies. (2) There is no high-resolution complex structures of BRACO19 binding to
scaffold, except for parallel stranded. Our binding energy data suggest a hypothesis that reconciles
antiparallel or the hybrid scaffold, except for parallel stranded. Our binding energy data suggest a
the conflict: the relative population shift of three scaffolds upon BRACO19 binding (i.e., an increase
hypothesis that reconciles the conflict: the relative population shift of three scaffolds upon BRACO19
of population of parallel scaffold, a decrease of populations of antiparallel and/or hybrid scaffold).
binding (i.e., an increase of population of parallel scaffold, a decrease of populations of antiparallel
This hypothesis appears to be consistent with the facts that BRACO19 was specifically designed based
and/or hybrid scaffold). This hypothesis appears to be consistent with the facts that BRACO19 was
on the structural requirements of the parallel scaffold and has since proven effective against a variety
specifically designed based on the structural requirements of the parallel scaffold and has since
of cancer cell lines as well as toward a number of scaffolds.
proven effective against a variety of cancer cell lines as well as toward a number of scaffolds.
For better molecular insights, the binding of BRACO19 to a duplex 20mer DNA (d([GC]10 )2 )
For better molecular insights, the binding of BRACO19 to a duplex 20mer DNA (d([GC]10)2) and
and to the parallel, anti-parallel and hybrid telomeric G-quadruplexes were investigated in this
to the parallel, anti-parallel and hybrid telomeric G-quadruplexes were investigated in this study
study using free ligand binding molecular dynamics simulations. Out of various binding modes
using free ligand binding molecular dynamics simulations. Out of various binding modes for each
for each system, the MM-GBSA binding energy calculations showed that the most stable binding
system, the MM-GBSA binding energy calculations showed that the most stable binding pose was
pose was the groove binding mode for the duplex, the top/bottom stacking mode for the parallel
the groove binding mode for the duplex, the top/bottom stacking mode for the parallel G-quadruplex,
G-quadruplex, the bottom stacking mode of the anti-parallel G-quadruplex and the top stacking
the bottom stacking mode of the anti-parallel G-quadruplex and the top stacking mode of the hybrid
mode of the hybrid G-quadruplex (Table S1). The order of the relative binding energy of BRACO19
G-quadruplex (Table S1). The order of the relative binding energy of BRACO19 to these DNA forms
to these DNA forms are as follows: −62.3 ± 4.5 kcal/mol of the top stacking to the parallel
are as follows: −62.3 ± 4.5 kcal/mol of the top stacking to the parallel G-quadruplex (ΔΔG = 0 kcal/mol),
G-quadruplex (∆∆G = 0 kcal/mol), −61.7 ± 8.0 kcal/mol of the groove binding to the duplex DNA
−61.7 ± 8.0 kcal/mol of the groove binding to the duplex DNA (ΔΔG = 0.6 kcal/mol), −53.9.4 ± 5.8
(∆∆G = 0.6 kcal/mol), −53.9.4 ± 5.8 kcal/mol of the bottom stacking to the anti-parallel G-quadruplex
kcal/mol of the bottom stacking to the anti-parallel G-quadruplex (ΔΔG = 8.4 kcal/mol) and −40.5 ±
(∆∆G = 8.4 kcal/mol) and −40.5 ± 5.4 kcal/mol of the top stacking to the hybrid G-quadruplex (∆∆G
5.4 kcal/mol of the top stacking to the hybrid G-quadruplex (ΔΔG = 21.8 kcal/mol). For all the systems,
= 21.8 kcal/mol). For all the systems, breaking down the binding energy indicated that the VDW
breaking down the binding energy indicated that the VDW term makes the biggest contribution to
term makes the biggest contribution to the total binding energy (Table S1). This indication suggests
the total binding energy (Table S1). This indication suggests introducing target or drug specific
introducing target or drug specific packing optimization as a prospect for further stabilization of the
packing optimization as a prospect for further stabilization of the G-quadruplex. A limitation of the
MMPBSA binding energy calculations are that they do not include the conformational changes
involved in the folding process of the G-quadruplexes nor do they consider the relative stability of
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G-quadruplex. A limitation of the MMPBSA binding energy calculations are that they do not include
the conformational changes involved in the folding process of the G-quadruplexes nor do they consider
the relative stability of the different scaffolds. Because of this, MMPBSA calculations alone may not be
sufficient enough to predict the most favorable scaffold under physiological conditions.
With groove binding predicted to be the least energetically favorable, and based on our visual
inspection of each trajectory, our data suggests that BRACO190 s groove binding pose is likely not stable
enough to maintain a prolonged binding event and that under a more extended timeline the groove
binding mode may function as an intermediate state preceding a more energetically favorable end
stacking pose. To support this, Figure S29A–C provide representative snapshots of three simulation
runs from each G-quadruplex system are presented. As for the anti-parallel system, we attribute the
comparable top and groove binding poses to the anti-parallel topology. Based on our observations
the diagonal loop (T11, T12, A13) atop the G-quartet, closest to the 50 terminal, obstructs BRACO190 s
ability to achieve a stable stacking pose on the top G-quartet. Therefore BRACO190 s major interaction
with the top of the anti-parallel G-quadruplex is with the TTA diagonal loop, which offers no benefit
over the groove binding pose in terms of binding interaction.
If these binding modes have comparable entropic energies then our relative binding energies
suggest that BRACO19 binds preferentially to the parallel G-quadruplex over the anti-parallel and the
hybrid G-quadruplexes if assuming equally abundant conformations in physiological condition.
In the same way, our relative binding energy data shows that BRACO19 binds preferentially
to the telomeric parallel G-quadruplexes over the DNA duplex. This qualitatively explains the
experimental observation of weak preferential binding affinity difference of BRACO19 on the two
DNA forms (40-fold of the selectivity). For that reason, it can be suggested that a ligand modification
that destabilizes the duplex groove binding mode but stabilizes the G-quadruplex top stacking
mode will enhance the binding selectivity of the ligand. For example, adding a rigid planar ring
fragment to the acridine may facilitate top stacking rather than groove binding and increase the
Van der Waals interactions in turn increasing selectivity and binding affinity of the prospective
drug towards the G-quadruplex. This suggestion is consistent with the original SAR data in the
development of BRACO19 from prototype BSU6048 in which the addition of the ring at position
9 (makings of BRACO19) increased the drug selectivity from 10-fold to 40-fold towards human
telomeric G-quadruplexes over duplex DNA [48,87,88]. The addition of the methylated anilino group,
as opposed to the hydrogenated aniline at the 9th position slightly decreased binding to the duplex,
while maintaining binding to the G-quadruplex [89]. It is also to be noted that the sidechains on
3 and 6 contribute to the groove binding of both DNA duplex and G-quadruplex which could be the
reason behind low selectivity. We observed the side chains of the 3rd and 6th position to play a role in
BRACO190 s ability to fully bind to the groove of the duplex DNA, but the side chains appear to play
less of a role in G-quadruplex binding; which we primarily observed as an interaction with the acridine
core. Thus, suggestions can be made to reduce the length of these side chains. These side chains exist in
protonated form at physiological pH however, Table S1 indicates that the contribution of electrostatic
interactions to the binding affinity is very low and therefore modifications can be suggested to the
substituents at 3rd and 6th position of the acridine. Modifications such as loss of positive charge which
would increase the hydrophobicity which could in fact increase the Van der Waals interactions and
reduction of the length of the side chains.
Encouragingly, the binding pose of BRACO19 to the parallel human telomeric G-quadruplex is
consistent with to the only available crystal structure of BRACO19 (PDB ID: 3CE5) (Figure 11). In both
the crystal structure and the structure from our study, the acridine core binds to the G-quartet closest
to the 30 terminal with the nitrogen from the acridine core facing inward in-line with the K+ cations.
The anilino group at the 9th position faces away from the G4 core and the two substituents at the 3rd
and 6th position are also positioned outward, allowing the drug to remain planar and stack onto the
G-quartet. Although a top binding pose was not reported in the crystal structure of the double stranded
parallel topology, our study suggests due to the symmetry of the single stranded parallel G-quadruplex
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topology both the top and bottom of the G-quadruplex core offer comparable binding opportunities for
BRACO19. In support of this, our MM-GBSA analysis showed the most energetically favorable top and
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G-quartet. We observed two possible outcomes for the mechanism involving 50 terminal base flipping:
(i) the 50 base will flip back on top of BRACO19 intercalating it onto the top G-quartet or (ii) the 50
terminal base will position itself in plane with BRACO19 and base pair; both mechanisms enhance
the binding interactions between BRACO19 and the DNA G-quadruplex. The anti-parallel DNA
G-quadruplex (Figure S30B) provides an example of two bases from the same loop changing position
in order to enhance the binding of BRACO19 to the DNA G-quadruplex. In this case, the flipping
upward of base T5 during the simulation run allowed base A7 to flip outward and reposition itself
around the outside of BRACO19 so that BRACO19 was partially intercalated to the groove of the
DNA G-quadruplex which maximized its binding interactions. The hybrid topology (Figure S30C)
provides an example of both a terminal and loop residues flipping outward to allow BRACO19 to
reposition into a binding pose that enhances its binding interactions. In this case, the 30 terminal
residue A23 and loop residue T13 both flip outward allowing BRACO19 to stack to the bottom of
the G-quadruplex. Residue A23 flips back on top of BRACO19 intercalating it while T13 remains
flipped outward to provide sufficient room for BRACO19. Together with the analysis of the dihedral
angles, the flexibility of both the terminal and loop residues -which through their conformational
changes allow BRACO19 to positon itself in a more favorable binding pose and enhance its binding
interactions show characteristics of an induced fit binding mechanism. It was by use of the free ligand
MD binding simulations, as opposed to rigid body docking, that we were able to observe the flipping
of the terminal and loop bases during the binding process which we suggest are integral for BRACO19
to achieve the most favorable binding pose.
4. Methods
4.1. Simulation Systems
A total of nine systems were constructed: a BRACO19 only system, a B-DNA duplex structure of
d([GC]10 )2 , the X-ray crystal structure of the parallel telomeric DNA G-quadruplex, the NMR solved
anti-parallel telomeric DNA G-quadruplex and the NMR-solved hybrid telomeric DNA G-quadruplex
and four DNA-ligand systems (Table 2). The B-DNA duplex structure of d([GC]10 )2 was built using
Maestro program. The four free ligand-DNA systems were constructed with a free BRACO19 molecule
that was 10 Å away from the DNA (Figure S1). A water box of truncated octahedron with 10 Å
water buffer was used to solvate the unbound system and was neutralized by K+ and 0.15 M KCl
was added. The DNA structures were represented by a refined version of the AMBER DNA OL15
(i.e., parm99bsc0 [90] + χOL4 [91] + ε/ζOL1 [92] + βOL1 [93] updates), water was represented by TIP3P
model [94] and the K+ ions were represented by the K+ model developed by Cheatham group [95].
The standard AMBER protocol was used to obtain the force field for the BRACO19 molecule: after the
geometry optimization of BRACO19 at the HF/6-31G* level, the molecular electrostatic potential (MEP)
of the BRACO19 molecule was calculated at the same theory level; then the partial charges of BRACO19
atoms were determined by MEP using Restrained Electrostatic Potential/RESP method with two stage
fitting [96]; and the AMBER GAFF2 [97] force field provided the rest of the force field parameters.
The supporting document of our previous paper [85] provides the BRACO19 force field in Mol2 format.
The nucleic acid simulations have been widely practiced in AMBER DNA force fields [81,98–101].
In our previous studies, the binding pathway of doxorubicin [101] and Telomestatin [83], anti-cancer
drugs to the B-DNA fragment [102] and to the human telomeric hybrid G-quadruplex [83], respectively
have been simulated.
4.2. Simulation Protocols
The ten production runs for all complex systems were conducted using the AMBER 16 simulation
package [97]. The detailed protocol followed our previous studies [83,102]. After minimizing the
energy, the Maxwell-Boltzmann distribution was used to conduct all simulation runs with different
initial velocities, which were assigned based on random seeds. For the free binding system, an extra
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500 ps pre-run at high temperature (500 K) was carried out to randomize the position and orientation
of the free ligand, while the receptor was fixed. Better sampling of binding poses and pathway was
enabled by multiple independent simulations. To equilibrate the system density, a short 1.0 ns MD
simulation in the NPT ensemble mode (constant pressure and temperature) was conducted, where the
DNA and ligand were subjected to Cartesian restraints (1.0 kcal/mol/Å). For the 500 ns production
run, the NVT ensemble mode (constant volume and temperature) was used to enhance the simulation
code stability. The representative trajectory for major binding modes was picked from each system
and extended to 2000 ns. All bonds connecting hydrogen atoms were constrained by SHAKE [103]
which enabled a 2.0 fs time step in the simulations. Long-range electrostatic interactions under
periodic boundary conditions were treated using the particle-mesh Ewald method [104] (the fourth
order of the B-spline charge interpolation, charge grid spacing of ~1.0 Å; and direct sum tolerance
of 10−5 ). The cutoff distance for short-range non-bonded interactions was 10 Å, with the long-range
Van der Waals interactions based on a uniform density approximation. To reduce the computation
cost, a two-stage RESPA approach [105] was used to calculate non-bonded forces where the short
range forces was updated once per time step and the long range forces was updated twice per time
step. The Langevin thermostat with a coupling constant of 2.0 ps was used to control the temperature.
The trajectories were saved at 50.0 ps intervals for analysis.
4.3. Convergence of Simulations
The initial structure was used as a reference to calculate the root mean square deviation (RMSD)
of DNA backbone. The stability of the DNA structures was indicated by the flat and small RMSDs
(Figures S2, S4, S6 and S8). An atom-to-atom distance cutoff of 3.0 Å was used to calculate atom
contacts between the DNA structure and BRACO19. The stable contact number indicated the steady
state of the simulation systems (Figures S3, S5, S7 and S9). We defined a stable complex as one with
greater than 10 atom contacts.
4.4. Binding Mode Identification
Accounting to the stability of the DNA backbone in the binding process, the DNA backbone of
the stable complexes was aligned by a least square fitting. Daura algorithm [106] was used to cluster
the aligned complexes into different structural families based on the 2 Å pair-wise RMSD cutoff of the
BRACO19 only without ligand fit. The centroid structure was defined as a structure with the largest
number of neighbors in the structural family and was used to represent that structural family. Based on
visual inspection, super-families corresponding to major binding modes were formed by merging the
centroid structures (Figure 3; Figures S14–S17).
4.5. Order Parameters to Characterize DNA-Drug Binding Pathway
The DNA-drug binding process was characterized by using five order parameters: hydrogen
bond analysis, drug-base dihedral angle, DNA/ligand RMSD, center-to-center and K+ -K+ distance
(R) and MM-GBSA binding energy (∆G). A hydrogen bond was defined by 3.5 Å distance cutoff
between H-bond donor and H-bond acceptor and 120◦ donor-H-acceptor angle cutoff. The hydrogen
bonds were calculated for the top/first, middle/second and bottom/third base tetrads. For the three
G-quadruplexes, the three G-tetrads were defined so that 50 is close to the first G-tetrad. The dihedral
angle between the plane of the stable G-tetrad of the DNA that is close to drug binding site and the
BRACO190 s ring plane was defined as the dihedral angle. After aligning the DNA, the ligand RMSD
was calculated with reference to the first frame of the trajectory. The length from the DNA center to
the drug molecule center was defined as the center-to-center distance (R). The distance between the K+
ions present in the DNA G-quadruplex was defined as K+ -K+ distance. The energetics of the bound
complexes were analyzed using the Molecular Mechanics Generalized Born-Surface Area (MM-GBSA)
54 module in the AMBER package (GB1 model with salt concentration of 0.15 M, mBondi radii set,
and surface tension of 0.0072 kcal/Å2 ) to avoid the large energy fluctuation of the explicit solvent.
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It was reported that even when considering the relative solvation free energy, good predictions
can be made for charged molecules by the GB models on the hydration free energy [107]. Under this
assumption, ions were removed from charged DNA systems in this study. This approach was validated
in our previous study, in which this MM-GBSA protocol successfully assessed the binding energy
of doxorubicin, an anti-cancer drug, to a B-DNA fragment (d(CGATCG)2) [102]. Under comparable
entropic terms, the relative binding free energy estimated by the MM-GBSA binding energies can
be used to rank drugs or their binding poses if a single molecule is considered [106]. It has been
established by systematic benchmarking studies up to 1864 crystal complexes that ranking of the
ligand binding affinity can be achieved by relative MM-GBSA binding energy calculations [108–110].
In a previous work we studied the use of MM-GBSA versus MM-PBSA as a predictor of BRACO190 s
relative binding energy (∆∆G) over a range of ionic strengths [85]. The highly comparable relative
binding energies in both the MM-GBSA and MM-PBSA calculations supports the use of MM-GBSA
in ranking the binding poses of BRACO19 in this study. The MM-GBSA binding energy for each
system was calculated from three simulations [84]: ligand only, DNA only and DNA-ligand complex
using Equation (1). Equation (2) is made up of four components: Van der Waals interaction energy
(VDW), hydrophobic interaction energy (SUR), electrostatic interaction (GBELE) and the change of the
conformation energy for DNA and ligand. These terms were calculated using Equations (3) and (4).
∆E = Ecomplex − EDN A_ f ree − Elig_ f ree

(1)

∆E = ∆Evdw + ∆ESUR + ∆EGBELE + ∆Ecom f ormation

(2)

∆Ex = Ex_complex − Ex_DN A_complex − Ex_lig_complex , x = VDW, SUR and GBELE

(3)

∆ECom f ormation = EDN A_ f rom_complex + Elig_ f rom_complex − EDN A_ f ree − Elig_ f ree

(4)

The standard backbone dihedral angles (α, β, γ, δ, ε and ζ) around the covalent bonds of
the deoxyribose and χ about the glycosidic bond were defined (Figure S27) to characterize the
conformational changes.
5. Conclusions
The detailed structural knowledge of the intramolecular human telomeric G-quadruplexes in
complex with a ligand is required for the rational design of human telomeric G-quadruplex binding
drugs. Despite high interest in the G-quadruplex binder BRACO19, a detailed binding mechanism
remains to be solved. In this study, free ligand molecular dynamics binding simulations were used
to probe and understand the binding nature of BRACO19, a potent human telomeric G-quadruplex
drug, to a B-DNA duplex and the three scaffolds of a single stranded human telomeric G-quadruplex.
The most stable binding mode, indicated by the MM-GBSA binding energy analysis, for the duplex
DNA is the groove binding mode, end stacking for the parallel G-quadruplex, bottom stacking for the
anti-parallel G-quadruplex and top stacking of hybrid G-quadruplexes. The similar binding affinity
of BRACO190 s groove binding mode with respect to both the duplex and the G-quadruplexes may
explain its lack of preferential binding selectivity. Therefore, a ligand modification that destabilizes
the duplex groove binding mode but stabilizes the G-quadruplex top stacking mode will improve
the binding selectivity of the ligand. Encouragingly, our study was able to produce both a top and
bottom binding mode that closely matched the description of BRACO19 in complex with a double
stranded parallel scaffold; the only available complex crystal structure with BRACO19. Our study
suggests that both ends of the single stranded parallel scaffold offer equal binding opportunity for
BRACO19 and is further supported by the 0.5 kcal/mol absolute binding energy difference (∆∆G)
which slightly favors the top stacking pose over the bottom. For the hybrid scaffold, BRACO19 was
observed in a comparable binding pose to the crystal structure of a Pt-tripod in complex with the
same hybrid scaffold of the human telomeric DNA G-quadruplex. Consistent use of a base flipping
mechanism provided evidence of an the use of an induced fit binding mechanism through the flexibility
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of both terminal and loop residues that underwent conformational changes ultimately enhancing
the binding interactions between the DNA G-quadruplexes and BRACO19. From our analysis of the
base flipping we identify two primary outcomes: (i) the base that flips outward will flip back after
BRACO19 repositions and enhance interactions through base pairing or intercalation interactions,
(ii) the base that flips outward provides sufficient room for BRACO19 to reposition and enhance its
binging interactions with other bases of the G-quadruplex. Our study presents a successful example of
the ability of molecular dynamic simulations with the latest AMBER force field to facilitate detailed
structural and dynamic information which will further decipher the binding nature of DNA ligands.
Supplementary Materials: Supplementary Materials are available online. The structure pdb file and the movie
file of the most stable binding pose for each DNA system is included in the supporting material. Also available is
the summary of BRACO19s activity against various cancer cell lines, RMSD and ligand-DNA contact plot for
each trajectory, representative structures of the most populated structural families for each system, additional
representative trajectories are included in the supporting document.
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